Thomas Hueso

7PUBLICATIONS
38CO-AUTHORS
NanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHumoural immunology and immunochemistryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 31, 2026
Convalescent Plasma Restores Viral Clearance After Anti-Spike Monoclonal Antibody Failure in Immunocompromised COVID-19 Patients: A Systematic Review and Meta-Analysis of Individual Patient Data.

|Apr 06, 2026
CD3xCD20 bispecific antibodies in transformed Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.

Morgane Brocard, Damien Roos-Weil, Lukshe Kanagaratnam

|Apr 01, 2025
Infectious Complications in Patients Treated With T-cell Engagers as Cancer Immunotherapies, a Descriptive Study From the REISAMIC Registry.

Thomas Hueso, Justin Cagnat, Kaïssa Ouali

|Mar 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World Analysis.

Thomas Hueso, Grégory Lazarian, Paul Chauvet

|Feb 02, 2022
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis.

Thomas Hueso, Anne-Sophie Godron, Emilie Lanoy

|Sep 07, 2020
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening.

Thomas Hueso, Kenneth Ekpe, Camille Mayeur

Pageof 2

Frequent Collaborators

2 joint publications

Karine Lacombe

1 joint publications

Marie Joncquel-Chevallier Curt

1 joint publications

Christophe Rodriguez

1 joint publications

Guillaume Ulmann